Description:[001] The present invention relates to the field of advanced medical diagnostics and computational healthcare systems, and more particularly to the application of artificial intelligence and deep learning techniques for the automated analysis of neuroimaging data to detect and classify neurodegenerative disorders. Specifically, the invention pertains to a novel dual-backbone deep learning framework that integrates transformer-based architectures and convolutional neural networks for enhanced feature extraction and predictive analysis. The disclosed system is designed for accurate staging of Alzheimer’s disease through the processing of medical imaging modalities such as magnetic resonance imaging (MRI) and related datasets. Furthermore, the invention lies at the intersection of computer vision, biomedical signal processing, and intelligent decision support systems, enabling improved clinical interpretation, early diagnosis, and progression monitoring of Alzheimer’s disease using hybrid deep learning methodologies.
BACKGROUND OF THE INVENTION
[002] Alzheimer’s disease is a progressive neurodegenerative disorder characterized by the gradual decline of cognitive functions, including memory, reasoning, and behavioral abilities. It is one of the leading causes of dementia worldwide and poses a significant burden on patients, caregivers, and healthcare systems. The disease typically progresses through multiple stages, ranging from normal cognitive function to mild cognitive impairment and eventually to severe dementia, making early and accurate stage prediction critically important for effective treatment and management.
[003] Conventional diagnostic methods for Alzheimer’s disease involve clinical assessments, neuropsychological tests, and imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET). While these methods provide valuable insights into brain structure and function, they are often dependent on expert interpretation and may suffer from inter-observer variability, limited sensitivity in early stages, and high operational costs. As a result, there is a growing demand for automated and reliable diagnostic tools that can assist clinicians in making accurate and timely decisions.
[004] In recent years, machine learning approaches have been introduced to assist in the diagnosis and classification of Alzheimer’s disease using medical imaging data. These approaches utilize handcrafted features and statistical models to identify patterns associated with disease progression. However, traditional machine learning techniques are limited in their ability to capture complex, high-dimensional relationships present in neuroimaging data, often resulting in suboptimal performance and reduced generalizability across diverse datasets.
[005] The emergence of deep learning, particularly convolutional neural networks (CNNs), has significantly improved the capability of automated diagnostic systems by enabling end-to-end learning directly from raw imaging data. CNN-based models can effectively extract spatial and structural features from brain images, leading to improved classification accuracy. Despite these advantages, CNNs primarily focus on local feature extraction and may struggle to capture long-range dependencies and global contextual information across different brain regions.
[006] Transformer-based architectures, originally developed for natural language processing tasks, have recently been adapted for computer vision applications. Vision transformers, including Swin Transformer models, utilize self-attention mechanisms to capture global relationships within data, enabling better modeling of complex patterns. While these models demonstrate strong performance in capturing contextual information, they often require large datasets and computational resources, and may not efficiently capture fine-grained spatial features compared to convolutional networks.
[007] Existing approaches that rely solely on either convolutional neural networks or transformer-based architectures are therefore limited in achieving optimal performance for Alzheimer’s disease stage prediction. The lack of integration between global contextual understanding and detailed spatial feature extraction leads to incomplete representation of critical disease markers in neuroimaging data. Consequently, there remains a need for a hybrid approach that combines the strengths of both methodologies.
[008] Several hybrid models have been proposed to address these limitations; however, they often involve complex architectures, inefficient feature fusion strategies, or lack adaptability to varying data distributions. Additionally, many existing systems do not incorporate effective preprocessing techniques or adaptive learning mechanisms, which are essential for handling variability in medical imaging data and improving model robustness.
[009] Another challenge in Alzheimer’s disease diagnosis is the variability in imaging data due to differences in acquisition protocols, scanner types, and patient-specific characteristics. This variability can significantly impact model performance and limit the scalability of existing solutions. Therefore, there is a need for a robust framework capable of generalizing across heterogeneous datasets while maintaining high prediction accuracy.
[010] Furthermore, current diagnostic systems often lack interpretability and integration capabilities with clinical workflows. Healthcare professionals require systems that not only provide accurate predictions but also offer insights into the underlying decision-making process. The absence of such features limits the practical adoption of automated diagnostic tools in real-world clinical environments.
[011] In view of the foregoing limitations, there exists a significant need for an improved system and method that leverages advanced deep learning architectures to provide accurate, efficient, and scalable prediction of Alzheimer’s disease stages. Such a system should effectively combine global and local feature extraction, incorporate adaptive feature fusion, and support reliable clinical decision-making, thereby addressing the shortcomings of existing technologies.
SUMMARY OF THE INVENTION
[012] The present invention provides a novel system and method for accurate prediction and classification of Alzheimer’s disease stages using an advanced dual-backbone deep learning framework. The invention is designed to overcome the limitations of conventional diagnostic systems by integrating complementary artificial intelligence architectures that enhance feature extraction, representation, and classification of neuroimaging data.
[013] In one aspect, the invention introduces a hybrid computational framework comprising two parallel feature extraction backbones, namely a Swin Transformer network and an EfficientNet model. The Swin Transformer backbone is configured to capture global contextual dependencies and hierarchical attention-based representations from brain imaging data, while the EfficientNet backbone is optimized to extract fine-grained spatial and structural features with high computational efficiency.
[014] In another aspect, the invention incorporates a robust data preprocessing module configured to standardize and enhance neuroimaging datasets prior to analysis. The preprocessing module performs operations including noise reduction, intensity normalization, skull stripping, segmentation of relevant brain regions, and data augmentation. These processes improve data quality, reduce variability, and enhance the performance and generalization capability of the deep learning framework.
[015] The invention further provides an adaptive feature fusion mechanism that combines the outputs generated by the dual-backbone architecture into a unified and discriminative feature representation. The fusion mechanism may include attention-based weighting, feature concatenation, and dimensionality reduction techniques to ensure optimal integration of global and local features while minimizing redundancy and preserving critical disease-related patterns.
[016] In an additional aspect, the invention includes a classification module configured to predict the stage of Alzheimer’s disease based on the fused feature representation. The classification module utilizes fully connected neural layers and a probabilistic output function to categorize input data into multiple disease stages, including normal cognition, mild cognitive impairment, early-stage Alzheimer’s disease, and advanced Alzheimer’s disease. The system may further provide confidence scores associated with each prediction to assist in clinical interpretation.
[017] The invention also introduces an intelligent training and optimization strategy that leverages transfer learning, adaptive learning rate scheduling, and advanced loss functions to improve model convergence and accuracy. The training framework is designed to operate efficiently with limited labeled medical data while maintaining high predictive performance across diverse datasets.
[018] In a further aspect, the proposed system is capable of handling heterogeneous and multi-source medical imaging data, thereby improving scalability and robustness in real-world clinical environments. The framework is adaptable to variations in imaging modalities, acquisition conditions, and patient-specific characteristics, ensuring consistent performance across different healthcare settings.
[019] The invention additionally provides an interface for visualization and clinical decision support, wherein prediction results are presented along with interpretable insights such as highlighted regions of interest and feature importance indicators. This enhances transparency and facilitates trust and adoption among healthcare professionals.
[020] The proposed system offers significant advantages over existing solutions, including improved prediction accuracy, enhanced feature representation, reduced computational complexity through efficient architecture design, and seamless integration into clinical workflows. The dual-backbone approach ensures a balanced combination of transformer-based contextual understanding and convolutional spatial analysis.
[021] Accordingly, the present invention addresses the shortcomings of prior art by providing a comprehensive, scalable, and intelligent framework for Alzheimer’s disease stage prediction, thereby contributing to early diagnosis, improved patient management, and advancement in AI-driven healthcare technologies.
BRIEF DESCRIPTION OF THE DRAWINGS
[022] The accompanying drawings are incorporated herein and form an integral part of the present disclosure, illustrating exemplary embodiments of the invention and serving to explain the principles and operation of the proposed dual-backbone deep learning framework. The drawings are intended to provide a conceptual understanding of the system architecture and workflow, and are not necessarily drawn to scale. It will be appreciated that the components illustrated in the figures are simplified representations and that various modifications may be made without departing from the scope of the invention.
[023] Figure 1 illustrates the overall system architecture of the proposed dual-backbone framework, depicting the interaction between the data acquisition module, preprocessing unit, Swin Transformer backbone, EfficientNet backbone, adaptive feature fusion mechanism, classification module, and the output prediction interface for Alzheimer’s disease stage determination.
[024] Figure 2 illustrates the operational workflow of the proposed system, showing the sequential process of neuroimaging data input, preprocessing, parallel feature extraction through dual backbones, feature fusion, classification, and generation of Alzheimer’s disease stage predictions along with associated confidence measures.
DETAILED DESCRIPTION OF THE INVENTION
Overview of the Invention
[025] The present invention discloses a comprehensive system and method for accurate prediction of Alzheimer’s disease stages using a dual-backbone deep learning architecture. The system is designed to integrate advanced transformer-based and convolutional neural network models to extract complementary features from neuroimaging data. By leveraging the strengths of both architectures, the invention enables enhanced detection of subtle structural and functional changes in the brain associated with disease progression.
System Architecture
[026] The system comprises multiple interconnected modules including a data acquisition module, preprocessing unit, dual-backbone feature extraction engine, adaptive feature fusion layer, classification module, and a visualization interface. These modules operate in a coordinated manner to process raw medical imaging data and generate accurate stage predictions of Alzheimer’s disease.
[027] The architecture is designed to support scalable deployment in both cloud-based and on-premise healthcare environments. The modular design allows integration with hospital information systems, radiology platforms, and electronic health records for seamless clinical adoption.
Data Acquisition Module
[028] The data acquisition module is responsible for collecting neuroimaging datasets such as magnetic resonance imaging (MRI), positron emission tomography (PET), or other relevant imaging modalities. The data may be sourced from clinical repositories, diagnostic centers, or publicly available medical datasets.
[029] In certain embodiments, the system may also incorporate auxiliary data including patient demographics, cognitive assessment scores, and clinical history to enhance prediction accuracy and contextual understanding.
Data Preprocessing Module
[030] The preprocessing module prepares the acquired data for analysis by performing a sequence of image enhancement and normalization operations. These operations include noise filtering, intensity normalization, skull stripping, spatial alignment, and segmentation of regions of interest such as the hippocampus and cortical areas.
[031] Data augmentation techniques such as rotation, translation, scaling, and contrast adjustments are applied to improve model generalization and reduce overfitting. The preprocessing stage ensures consistency across heterogeneous datasets and enhances the quality of input data.
Dual-Backbone Feature Extraction Framework
[032] A key aspect of the invention is the implementation of a dual-backbone architecture comprising a Swin Transformer network and an EfficientNet model operating in parallel. Each backbone processes the preprocessed input data independently to extract distinct and complementary feature representations.
[033] The Swin Transformer backbone employs a hierarchical attention mechanism with shifted windows to capture global contextual relationships across different regions of the brain. This enables the model to identify long-range dependencies and subtle variations that are indicative of neurodegenerative progression.
[034] The EfficientNet backbone utilizes a compound scaling approach that balances network depth, width, and resolution to efficiently extract fine-grained spatial features. It is particularly effective in capturing local structural patterns and anatomical details within brain images.
[035] The parallel operation of both backbones ensures that the system benefits from both global context awareness and detailed spatial analysis, thereby providing a comprehensive representation of the input data.
Adaptive Feature Fusion Mechanism
[036] The outputs generated by the Swin Transformer and EfficientNet backbones are forwarded to an adaptive feature fusion module. This module is designed to combine the complementary feature maps into a unified representation that enhances discriminative capability.
[037] In one embodiment, the fusion mechanism includes attention-based weighting, feature concatenation, and normalization layers. The system dynamically assigns importance to features extracted from each backbone, ensuring optimal contribution from both global and local representations.
[038] The fused feature vector is further refined using dimensionality reduction techniques and nonlinear transformations to improve computational efficiency and classification performance.
Classification Module
[039] The classification module receives the fused feature representation and processes it through a series of fully connected neural layers. The final output layer employs a probabilistic function to classify the input data into predefined Alzheimer’s disease stages.
[040] The predicted stages include normal cognition, mild cognitive impairment, early-stage Alzheimer’s disease, and advanced Alzheimer’s disease. The system may also generate confidence scores associated with each prediction to provide additional insight for clinical decision-making.
Training and Optimization Strategy
[041] The system is trained using a supervised learning approach with labeled neuroimaging datasets. Transfer learning is employed to initialize the backbone networks with pretrained weights, thereby reducing training time and improving performance.
[042] The training process incorporates advanced optimization techniques including adaptive learning rate scheduling, regularization methods, and cross-entropy loss minimization. Validation mechanisms such as early stopping and model checkpointing are used to prevent overfitting and ensure robustness.
Model Interpretability and Visualization
[043] The invention further provides mechanisms for model interpretability by generating visual explanations of prediction results. Techniques such as attention maps and feature importance visualization are used to highlight brain regions that contribute significantly to the classification outcome.
[044] These visual outputs assist clinicians in understanding the reasoning behind model predictions, thereby improving trust and facilitating integration into clinical workflows.
Deployment and Clinical Integration
[045] The proposed system can be deployed as a standalone diagnostic tool or integrated into existing healthcare infrastructures. It supports real-time or batch processing of medical imaging data and can be accessed through user-friendly interfaces by healthcare professionals.
[046] The system is adaptable to various clinical settings and can be configured to operate with different imaging modalities and data sources, ensuring flexibility and scalability in real-world applications.
Advantages of the Invention
[047] The present invention offers several advantages over existing approaches, including improved prediction accuracy through hybrid feature extraction, efficient computation enabled by optimized network design, and enhanced robustness across diverse datasets.
[048] The dual-backbone architecture ensures a balanced integration of global contextual understanding and local spatial feature extraction, which is critical for accurate detection of Alzheimer’s disease progression.
[049] In conclusion, the invention provides an advanced and reliable framework for automated Alzheimer’s disease stage prediction by combining transformer-based and convolutional neural network methodologies. The system addresses the limitations of prior art and offers a scalable, interpretable, and high-performance solution for AI-driven medical diagnostics.
[050] The present invention provides a robust and intelligent system for the accurate prediction of Alzheimer’s disease stages by leveraging a dual-backbone deep learning framework that integrates the strengths of Swin Transformer and EfficientNet architectures. The proposed approach effectively addresses the limitations of conventional diagnostic methods and existing artificial intelligence models by combining global contextual feature extraction with detailed spatial analysis. This results in improved classification accuracy, enhanced reliability, and better generalization across diverse neuroimaging datasets.
[051] The invention significantly contributes to the field of medical diagnostics by enabling early detection and precise staging of Alzheimer’s disease, which is critical for timely clinical intervention and patient management. The integration of adaptive feature fusion and advanced training strategies further enhances the performance and scalability of the system, making it suitable for deployment in real-world healthcare environments. Additionally, the inclusion of interpretability features supports clinical decision-making by providing insights into model predictions.
[052] In future implementations, the system may be extended to incorporate multimodal data sources, including genetic information, biochemical markers, electronic health records, and longitudinal patient data, to improve predictive accuracy and enable personalized diagnosis. The framework may also be adapted for the detection and classification of other neurodegenerative disorders such as Parkinson’s disease and Huntington’s disease, thereby broadening its applicability.
[053] Further advancements may include the integration of federated learning techniques to ensure data privacy and secure model training across multiple healthcare institutions without sharing sensitive patient data. The system can also be enhanced with real-time processing capabilities and edge computing integration to support faster and decentralized diagnosis in remote or resource-limited settings.
[054] Accordingly, the present invention not only provides a novel and efficient solution for Alzheimer’s disease stage prediction but also establishes a foundation for future innovations in AI-driven healthcare systems, contributing to improved diagnostic accuracy, patient outcomes, and the advancement of intelligent medical technologies.
, Claims:1. A system for predicting stages of Alzheimer’s disease comprising a dual-backbone deep learning framework including a Swin Transformer network and an EfficientNet model configured to extract features from neuroimaging data.
2. The system as claimed in claim 1, wherein the Swin Transformer network is configured to capture global contextual and hierarchical relationships from brain imaging datasets using attention mechanisms.
3. The system as claimed in claim 1, wherein the EfficientNet model is configured to extract fine-grained spatial and structural features from the neuroimaging data using convolutional operations.
4. The system as claimed in claim 1, further comprising a preprocessing module configured to perform noise reduction, normalization, segmentation, and data augmentation on input medical images.
5. The system as claimed in claim 1, further comprising an adaptive feature fusion module configured to combine outputs from the Swin Transformer network and the EfficientNet model into a unified feature representation.
6. The system as claimed in claim 1, wherein the adaptive feature fusion module employs attention-based weighting and feature concatenation to enhance discriminative feature representation.
7. The system as claimed in claim 1, further comprising a classification module configured to predict Alzheimer’s disease stages including normal cognition, mild cognitive impairment, early-stage Alzheimer’s disease, and advanced Alzheimer’s disease.
8. The system as claimed in claim 1, wherein the framework utilizes transfer learning and adaptive optimization techniques for improved training efficiency and prediction accuracy.
9. The system as claimed in claim 1, further configured to generate probability-based outputs and visual interpretability maps to assist clinical decision-making.
10. A method for predicting Alzheimer’s disease stages comprising acquiring neuroimaging data, preprocessing the data, extracting features using a dual-backbone architecture including a Swin Transformer and an EfficientNet model, performing adaptive feature fusion, and classifying the data into disease stages.